has more than 30 years of experience of medical device regulation and clinical trials with an emphasis on emerging technologies.
She is founder and President of MedPass International, the leading European CRO and consultancy for the development and market access of new medical technologies. Following early experience gained in a French start up that went on to receive PMA approval in the US, she created MedPass 25 years ago to assemble teams of highly skilled regulatory and clinical experts that could be outsourced to start up companies enabling them to achieve their goals cost efficiently. During this time, MedPass has successfully helped over 1,000 medical device companies worldwide bring new technologies to the EU market.
Sarah is a recognized expert in EU medical device regulation and clinical investigations. She has spoken at and chaired conferences organized by RAPS and Medtec Ireland. She has written recent articles for industry trade journals. Sarah is American and holds a degree in Engineering and Applied Science from Yale University.